Edgewise Therapeutics Inc. Common Stock vs Illinois Tool Works Inc. — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Illinois Tool Works Inc. trades at $269.47 (market cap $75.85B). The key difference: Illinois Tool Works Inc. is far larger — about 19.3× Edgewise Therapeutics Inc. Common Stock's market cap, and Illinois Tool Works Inc. pays a 2.58% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Illinois Tool Works Inc. for 66 Days on average.
| EWTX | ITW | |
|---|---|---|
Market Cap | $3.94B | $75.85B |
Volume | 810,104 | 960,368 |
Sector | Health | Industrials |
52-Week High | $48.35 | $299.60 |
52-Week Low | $14.89 | $241.07 |
Typical Hold Time | 0 Days | 66 Days |
Enterprise Value | $3.48B | $84.70B |
Dividend Yield | — | 2.58% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ITW trades at $269.47, up 1.64% with consistent earnings beats in recent quarters. The stock shows bearish technical signals but maintains strong fundamentals with 19.39% net margins and 104.65% ROE. Recent dividend increase to $1.72 reinforces its Dividend King status with 59 years of growth. Revenue stability around $16B and operational cash flow exceeding $3B demonstrate business resilience despite mixed analyst sentiment.
Outlook remains balanced with upside to $276.86 consensus target but faces headwinds from elevated P/E of 24.12 and bearish technical momentum. The company's disciplined capital allocation and sector diversification provide stability, though automotive and foodservice weaknesses present near-term challenges. Valuation appears full given current growth rates.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →